Anti-saccharomyces cerevisiae antibodies in first-degree relatives of celiac disease patients

Journal of Clinical Gastroenterology

Volumn 44, Issue 4, 2010, Pages 308-

  Da Silva Kotze, Lorete Maria ^a   Nisihara, Renato Mitsunori ^b   Nass, Flávia Raphaella ^b   Theiss, Petra Mirella ^a   Silva, Isabela Goldner ^b   Da Rosa Utiyama, Shirley Ramos ^b  

^a PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGUS ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; SACCHAROMYCES CEREVISIAE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; CELIAC DISEASE; DISEASE ASSOCIATION; FAMILIAL DISEASE; FAMILY RELATION; HUMAN; INTESTINE MUCOSA PERMEABILITY; LETTER; PATIENT MONITORING; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTIBODIES; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; FAMILY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PREVALENCE; SACCHAROMYCES CEREVISIAE; YOUNG ADULT;

EID: 77949972713     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181bea0d4     Document Type: Letter

References (10)

1. Giafer MH, Clark A, Holdsworth CD. Antibodies to Saccharomyces cerevisiae in patients with Crohn,s disease and their possible pathogenic importance. Gut. 1992; 33:1071-1075.
2. Hollander D. Intestinal permeability, leaky gut, and intestinal disorders. Curr Gastroenterol Rep. 1999;1:410-416.
3. Sutton CL, Yang H, Li Z, et al. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn,s disease. Gut. 2000;46:58-63.
4. Reese GE, Constantinides VA, Simillis A, et al. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Am J Gastroenterol. 2006;101:2410-2422.
5. Vogelsang H, Wyatt J, Penner E, et al. Screening for celiac disease in first-degree relatives of patients with celiac disease by lactulose/mannitol test. Am J Gastroenterol. 1995;90:1838-1842.
6. van Elburg RM, Uil JJ, Mulder CJ, et al. Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease. Gut. 1993;34:354.
7. Granito A, Zauli D, Muratori P, et al. Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet. Aliment Pharmacol Ther. 2005;21:881-887.
8. Mallent-Hent RC, Mary B, von Blomberg E, et al. Disappearance of anti-Saccharomyces cerevisiae antibodies in coeliac disease during a gluten-free diet. Europ J Gastroenterol Hepatol. 2006;18:75-78.
9. Kotze LM, Utiyama SR, Nisihara RM, et al. Antiendomysium antibodies in Brazilian patients with celiac disease and their first-degree relatives. Arq Gastroenterol. 2001;38:94-103.
10. Fasano A, Shea-Donohue T. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune disease. Nature Clin Pract Gastroenterol Hepatol. 2005;2: 416-422.